Modern Care Journal

Published by: Kowsar

Protective Effects of Quercetin on Hyperglycemia and Stress Proteins Expression in Rats with Streptozocin-Induced Diabetes

Mina Hemmati 1 , 2 , * , S Elham Mostafavi 3 , Asghar Zarban 1 and Reyhane Hoshyar 2
Authors Information
1 Biochemistry Department, Birjand University of Medical Sciences, Birjand, Iran
2 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
3 Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Modern Care Journal: 15 (2); e64964
  • Published Online: April 28, 2018
  • Article Type: Research Article
  • Received: February 5, 2018
  • Revised: March 21, 2018
  • Accepted: April 3, 2018
  • DOI: 10.5812/modernc.64964

To Cite: Hemmati M, Mostafavi S E, Zarban A, Hoshyar R. Protective Effects of Quercetin on Hyperglycemia and Stress Proteins Expression in Rats with Streptozocin-Induced Diabetes, Mod Care J. Online ahead of Print ; 15(2):e64964. doi: 10.5812/modernc.64964.

Copyright © 2018, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. World Health Organization. WHO. 2014, [cited 14 Nov 2014]. Available from:
  • 2. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24-38. doi: 10.1002/jbt.10058. [PubMed: 12616644].
  • 3. Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. Markers of Oxidative Stress during Diabetes Mellitus. J Biomark. 2013;2013:378790. doi: 10.1155/2013/378790. [PubMed: 26317014]. [PubMed Central: PMC4437365].
  • 4. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res. 2005;51(2):117-23. doi: 10.1016/j.phrs.2004.06.002. [PubMed: 15629256].
  • 5. Mahesh T, Menon VP. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res. 2004;18(2):123-7. doi: 10.1002/ptr.1374. [PubMed: 15022163].
  • 6. Imatoh T, Sugie T, Miyazaki M, Tanihara S, Baba M, Momose Y, et al. Is heat shock protein 60 associated with type 2 diabetes mellitus? Diabetes Res Clin Pract. 2009;85(2):208-12. doi: 10.1016/j.diabres.2009.06.004. [PubMed: 19576649].
  • 7. Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M, Garrido C. Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med. 2008;12(3):743-61. doi: 10.1111/j.1582-4934.2008.00273.x. [PubMed: 18266962]. [PubMed Central: PMC4401125].
  • 8. Gorovits R, Czosnek H. The Involvement of Heat Shock Proteins in the Establishment of Tomato Yellow Leaf Curl Virus Infection. Front Plant Sci. 2017;8:355. doi: 10.3389/fpls.2017.00355. [PubMed: 28360921]. [PubMed Central: PMC5352662].
  • 9. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002;295(5561):1852-8. doi: 10.1126/science.1068408. [PubMed: 11884745].
  • 10. Wu C. Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol. 1995;11:441-69. doi: 10.1146/annurev.cb.11.110195.002301. [PubMed: 8689565].
  • 11. Mahgoub S, Youns M, Bassyouni A, Hassan Z. Serum levels of heat shock protein 27 as a potential marker of diabetic nephropathy in Egyptians with type 2 diabetes. J Appl Pharm Sci. 2012;2(11):14-20. doi: 10.7324/japs.2012.21104.
  • 12. Sayed KM, Mahmoud AA. Heat shock protein-70 and hypoxia inducible factor-1alpha in type 2 diabetes mellitus patients complicated with retinopathy. Acta Ophthalmol. 2016;94(5):e361-6. doi: 10.1111/aos.12919. [PubMed: 26725915].
  • 13. Jeong SM, Kang MJ, Choi HN, Kim JH, Kim JI. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr Res Pract. 2012;6(3):201-7. doi: 10.4162/nrp.2012.6.3.201. [PubMed: 22808343]. [PubMed Central: PMC3395784].
  • 14. Agius L. Targeting hepatic glucokinase in type 2 diabetes: weighing the benefits and risks. Diabetes. 2009;58(1):18-20. doi: 10.2337/db08-1470. [PubMed: 19114725]. [PubMed Central: PMC2606869].
  • 15. Gonzalez-Mujica F, Motta N, Estrada O, Perdomo E, Mendez J, Hasegawa M. Inhibition of hepatic neoglucogenesis and glucose-6-phosphatase by quercetin 3-O-alpha(2''-galloyl)rhamnoside isolated from Bauhinia megalandra leaves. Phytother Res. 2005;19(7):624-7. doi: 10.1002/ptr.1704. [PubMed: 16161025].
  • 16. Abdelmoaty MA, Ibrahim MA, Ahmed NS, Abdelaziz MA. Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian J Clin Biochem. 2010;25(2):188-92. doi: 10.1007/s12291-010-0034-x. [PubMed: 23105908]. [PubMed Central: PMC3453107].
  • 17. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem Pharmacol. 1991;42(9):1673-81. doi: 10.1016/0006-2952(91)90501-U. [PubMed: 1656994].
  • 18. Rao YK, Geethangili M, Fang SH, Tzeng YM. Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: a comparative study. Food Chem Toxicol. 2007;45(9):1770-6. doi: 10.1016/j.fct.2007.03.012. [PubMed: 17475387].
  • 19. Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr. 2005;135(10):2299-304. doi: 10.1093/jn/135.10.2299. [PubMed: 16177186].
  • 20. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol. 2003;135C(3):357-64. doi: 10.1016/S1532-0456(03)00140-6. [PubMed: 12927910].
  • 21. Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325-37. doi: 10.1016/j.ejphar.2008.03.008. [PubMed: 18417116].
  • 22. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 1976;15(2):212-6. doi: 10.1016/0006-2944(76)90049-1. [PubMed: 962904].
  • 23. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996;239(1):70-6. doi: 10.1006/abio.1996.0292. [PubMed: 8660627].
  • 24. Ji J, Zhang J, Huang G, Qian J, Wang X, Mei S. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett. 2009;583(4):759-66. doi: 10.1016/j.febslet.2009.01.034. [PubMed: 19185571].
  • 25. Valavi M, Mezginejad F, Haghighi F, Hemmati M, Zarban A, Rabiei Gask E. Effectiveness of aqueous and alcoholic extracts of barberry, jujube, and saffron against oxidative stress in streptozotocin-induced diabetic rats. Mod Care J. 2016;13(3). doi: 10.5812/modernc.11162.
  • 26. Alam MM, Meerza D, Naseem I. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci. 2014;109(1):8-14. doi: 10.1016/j.lfs.2014.06.005. [PubMed: 24946265].
  • 27. Shetty AK, Rashmi R, Rajan MGR, Sambaiah K, Salimath PV. Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats. Nutrition Research. 2004;24(5):373-81. doi: 10.1016/j.nutres.2003.11.010.
  • 28. Jung UJ, Lee MK, Park YB, Kang MA, Choi MS. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol. 2006;38(7):1134-45. doi: 10.1016/j.biocel.2005.12.002. [PubMed: 16427799].
  • 29. Shukla R, Padhye S, Modak M, Ghaskadbi SS, Bhonde RR. Bis(quercetinato)oxovanadium IV Reverses Metabolic Changes in Streptozotocin-Induced Diabetic Mice. Rev Diabet Stud. 2007;4(1):33-43. doi: 10.1900/RDS.2007.4.33. [PubMed: 17565414]. [PubMed Central: PMC1892525].
  • 30. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes. 2002;51(4):1102-9. doi: 10.2337/diabetes.51.4.1102. [PubMed: 11916932].
  • 31. Oksala NK, Laaksonen DE, Lappalainen J, Khanna S, Nakao C, Hanninen O, et al. Heat shock protein 60 response to exercise in diabetes: effects of alpha-lipoic acid supplementation. J Diabetes Complications. 2006;20(4):257-61. doi: 10.1016/j.jdiacomp.2005.07.008. [PubMed: 16798478].
  • 32. Hooper PL, Hooper PL. Inflammation, heat shock proteins, and type 2 diabetes. Cell Stress Chaperones. 2009;14(2):113-5. doi: 10.1007/s12192-008-0073-x. [PubMed: 18720028]. [PubMed Central: PMC2727993].
  • 33. Gruden G, Bruno G, Chaturvedi N, Burt D, Schalkwijk C, Pinach S, et al. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes. 2008;57(7):1966-70. doi: 10.2337/db08-0009. [PubMed: 18390793]. [PubMed Central: PMC2453614].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments